Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 545 - 552 of 11616 results
New Biden Executive Order Emphasizes Women’s Health
March 27, 2024| Alert| Viewpoint
A Mintz Health Care Roundtable: Current Trends in State Health Care Transaction Review and What to Expect in 2024
March 27, 2024| Blog| Viewpoint
The CDC Issues New COVID-Related Guidance: What This Means for Employers
March 26, 2024| Blog| Viewpoint
Further Updates to the CPPA Proposed Regulations: Risk Assessments and Automated Decisionmaking Technology
March 25, 2024| Blog| Viewpoint
Q&A with Guests from the Mintz’s Health Law Diagnosed Podcast Episode, Emerging Role of AI in Health Care
March 25, 2024| Blog| Viewpoint
The Plan Sponsor's Guide to Drug Formularies and Prior Authorizations
March 25, 2024| News
Mintz Sees Revenue Hit All-Time High
March 25, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.